GH FRAG 176–191

Advanced Metabolic Peptide

GH FRAG 176–191

Product Overview

GH Fragment 176–191 is a synthetic peptide corresponding to the C-terminal amino acid sequence (176–191) of human growth hormone (hGH). In controlled laboratory research environments, it is investigated for its selective interaction with lipid metabolism signaling pathways, particularly those associated with adipose tissue regulation and lipolytic mechanisms.

Unlike full-length growth hormone, this fragment is commonly studied for its targeted molecular activity in experimental metabolic models, without broader activation of complete growth hormone receptor pathways.

At Nexzya Bioscience, GH Frag 176–191 is produced under stringent research-grade manufacturing standards. Each batch undergoes advanced analytical verification to confirm molecular identity, structural integrity, and purity specifications. Our commitment to precision and reproducibility ensures that laboratories receive compounds suitable for high-level metabolic and biochemical investigation.

Key Characteristics

  • Synthetic C-terminal fragment of human growth hormone (176–191)

  • Precisely defined amino acid sequence

  • High-purity research-grade peptide

  • Molecular identity validated via advanced analytical techniques

  • Investigated for selective lipid metabolism pathway interaction

  • Commonly studied in adipose tissue signaling models

  • Examined in experimental lipolytic mechanism research

  • Designed to avoid full-length GH receptor pathway activation in research contexts

  • Stable under recommended laboratory storage conditions

  • Batch-specific documentation and traceability available

Direct Research Applications & Potential Benefits

  • Supports experimental investigation of lipid metabolism signaling

  • Enables focused study of adipocyte pathway dynamics

  • Assists in analyzing selective lipolytic signaling mechanisms

  • Contributes to metabolic regulation research frameworks

  • Facilitates deeper molecular understanding of C-terminal GH fragment activity

Final Overview

GH Frag 176–191 from Nexzya Bioscience reflects our laboratory’s commitment to scientific accuracy, analytical rigor, and research excellence. Manufactured exclusively for controlled laboratory investigation, this peptide is developed to meet strict research-grade standards, ensuring reliability and reproducibility in advanced metabolic studies.

When precision matters in peptide-based metabolic research, Nexzya Bioscience provides a dependable foundation for experimental advancement.

Request Technical Information

To receive detailed analytical reports, batch documentation, and technical specifications for GH Frag 176–191, please complete the form below with your name and email.

Our scientific team will provide comprehensive information tailored to your research requirements.

Advanced Peptide Science & Biomolecular Research

South Korea — 대한민국
Czech Republic — Česká republika

Resources

NEXZYA™ Bioscience | Since 1986 All Rights Reserved